APA

Tsavaris N., Charalambidis G., Ganas N., Pagou M., Karabellis A., Mylonakis N., Benou N., Tsikalakis D. & Kosmidis P. (19950525). Ondansetron versus metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to regard to electrolyte imbalance. : Acta oncologica (Stockholm, Sweden).

Chicago

Tsavaris N, Charalambidis G, Ganas N, Pagou M, Karabellis A, Mylonakis N, Benou N, Tsikalakis D and Kosmidis P. 19950525. Ondansetron versus metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to regard to electrolyte imbalance. : Acta oncologica (Stockholm, Sweden).

Harvard

Tsavaris N., Charalambidis G., Ganas N., Pagou M., Karabellis A., Mylonakis N., Benou N., Tsikalakis D. and Kosmidis P. (19950525). Ondansetron versus metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to regard to electrolyte imbalance. : Acta oncologica (Stockholm, Sweden).

MLA

Tsavaris N, Charalambidis G, Ganas N, Pagou M, Karabellis A, Mylonakis N, Benou N, Tsikalakis D and Kosmidis P. Ondansetron versus metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to regard to electrolyte imbalance. : Acta oncologica (Stockholm, Sweden). 19950525.